CGMs are prescribed to diabetics to monitor their blood sugar. They're now available and becoming wildly popular for over-the ...
The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it’s unclear whether they can ...
Cardinal Health’s planned acquisition of Advanced Diabetes Supply Group for $1.1 billion marries its logistics and ...
GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...
Hims & Hers introduced a new tracker to monitor shortages of GLP-1 weight loss and diabetes drugs, responding to the FDA's decision to end the compounded versions, Yahoo Finance reported Nov. 13.
Balancing your blood sugar and reducing the risk of health issues can be a challenge for people with diabetes when a cold or ...